These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18842333)

  • 1. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
    Weng D; Song X; Xing H; Ma X; Xia X; Weng Y; Zhou J; Xu G; Meng L; Zhu T; Wang S; Ma D
    Cancer Lett; 2009 Jan; 273(2):257-65. PubMed ID: 18842333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway.
    Xing H; Cao Y; Weng D; Tao W; Song X; Wang W; Meng L; Xu G; Zhou J; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):213-23. PubMed ID: 18158623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction effect of rapamycin combined paclitaxel on apoptosis of ovarian cancer cell lines A2780 and SKOV3 and the molecular mechanism].
    Ma XY; Wang SX; Liu Y; Liu RH; Lu YP; Ma D
    Ai Zheng; 2007 Apr; 26(4):367-70. PubMed ID: 17430653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
    Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
    Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
    Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of spindle checkpoint on Akt2-mediated paclitaxel-resistance in A2780 ovarian cancer cells.
    Zhou T; Bao Y; Ye S; Weng D; Chen G; Lu Y; Ma D; Wang S
    J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):206-11. PubMed ID: 20407875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
    Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
    Xiong H; Yu S; Zhuang L; Xiong H
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):65-7. PubMed ID: 17393113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
    Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
    Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
    Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.
    Xia X; Ji T; Liu R; Weng Y; Fang Y; Wang Z; Xu H
    Eur J Gynaecol Oncol; 2015; 36(6):662-6. PubMed ID: 26775347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.
    Wang Z; Xie Y; Wang H
    Cancer Biol Ther; 2005 Jul; 4(7):716-9. PubMed ID: 15970709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of survivin gene expression in ovarian cancer cell line CAOV3 after chemotherapy in vitro].
    Zhang SL; Jiang T; Lin B; Zhao CQ; Meng LR
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):482-5. PubMed ID: 15347474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells.
    Xing H; Weng D; Chen G; Tao W; Zhu T; Yang X; Meng L; Wang S; Lu Y; Ma D
    Cancer Lett; 2008 Mar; 261(1):108-19. PubMed ID: 18171600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].
    Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J; Liu P; Mao H; Wanga A; Zhang X
    Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly.
    Hu Q; Li W; Hu X; Hu Q; Shen J; Jin X; Zhou J; Tang G; Chu PK
    Biomaterials; 2012 Sep; 33(27):6580-91. PubMed ID: 22717365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.